Related Experiment Video
Updated: Jun 12, 2026
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
The management of Peyronie's disease: evidence-based 2010 guidelines
David Ralph1, Nestor Gonzalez-Cadavid, Vincenzo Mirone
1Institute of Urology, London, UK. dralph@andrology.co.uk
Introduction:
The field of Peyronie's disease is evolving and there is need for a state-of-the-art information in this area.
Aim:
To develop an evidence-based state-of-the-art consensus report on the management of Peyronie's disease.
Methods:
To provide state-of-the-art knowledge regarding the prevalence, etiology, medical and surgical management of Peyronie's Disease, representing the opinion of leading experts developed in a consensus process over a 2-year period.
Main Outcome Measures:
Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation, and debate.
Conclusions:
The real etiology of Peyronie's disease and the mechanisms of formation of the plaque still remain obscure. Although conservative management is obtaining a progressively larger consensus among the experts, surgical correction still remains the mainstay treatment for this condition.
Related Concept Videos
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Peripheral Artery Disease III: Interprofessional Care
01:26Atherosclerosis III: Management
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:26Angina IV: Management
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...